The following is a summary of “Collagen turnover biomarkers to predict outcome of patients with biliary cancer,” published in ...
20d
Medpage Today on MSNctDNA Testing Shows Promise for Influencing Colorectal Cancer TreatmentPatients who had positive ctDNA tests after surgery were almost twice as likely to be alive at 3 years if they received adjuvant celecoxib in addition to chemotherapy, whereas the ...
12don MSN
Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the ...
The increases were even higher in individuals over 60, those with preexisting conditions such as diabetes or heart disease, and patients with elevated levels of carcinoembryonic antigen (CEA), a ...
A2 Biotherapeutics has secured $80m in funding to advance its pipeline of CAR-T cell therapies for solid tumour cancers.
Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices ...
9d
AZoSensors on MSNLow-Cost Sensor for Lung Cancer BiomarkersCranfield University's new sensor detects lung cancer biomarkers quickly, supporting precision medicine and improving early ...
A2 Bio is currently conducting two seamless phase 1/2 clinical studies: EVEREST-1 studying A2B530 for pancreatic, lung and colorectal cancers by targeting carcinoembryonic antigen (CEA); and ...
Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even before symptoms occur.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results